The number of Americans hospitalized with COVID-19 is expected to exceed the peaks seen in April and July.
The highly anticipated late-stage results are the first to be announced by a pharmaceutical company conducting a coronavirus vaccine trial.
After four years of relentless attacks on science, researchers and doctors are hopeful that Biden will fight the pandemic and climate change.
Doctors and scientists expect a night-and-day difference in how the Biden administration will seek to handle the coronavirus. Is it too late?
With the critical state going down to the wire, here are the rules for how such a scenario could unfold.
"Ensuring that ill voters can vote while maintaining poll worker and voter safety will be essential," public health officials say.
A new study has found that, in states with rising COVID-19 deaths, voter support for Trump and Republican senators has dropped by margins big enough to swing some tight races.
"Some of the scientists have come to a point where they realize they have to speak out as a matter of life and death," said one expert.
"We need the public institutions to have a clear message based on science and not to be announcing something on Friday and pulling it out on Monday," said one scientist.
The disclosures from the two frontrunners, Pfizer and Moderna, come as public trust in a coronavirus vaccine is declining.
As the coronavirus vaccine is thrust into the center of the US presidential election, experts fear that public trust in the vaccine is taking a serious hit.
“I worry it will be Armageddon for the vaping industry.”
A Penn State official retracted saying a third of Big 10 football players with coronavirus infections had suffered heart injuries. But experts confirmed they are seeing heart muscle injuries in many patients.
“A deadly barrage” of pandemics is coming, a new report warns.
The first lesson of any vaccination program? “You have to get people on board with getting the vaccine.”
“People may die unnecessarily because the administration has allowed an ideological special interest group to hijack biomedical research,” one expert said, citing the wide use of fetal cells in coronavirus vaccine research.
“A lot of people are getting hurt by this senseless act.”
US hospitals are now treating around 1,500 patients a day with antibodies found in the blood of COVID-19 survivors.
“I can’t see how this is done, frankly, before the middle of next year,” said one expert, of a coronavirus vaccine.
Seen as the “gold standard” in many areas of medical research, fetal cells are widely used in coronavirus vaccine research.